SEC Form 4 · accession 0001144204-17-031582
MUSTANG BIO, INC. · MBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fortress Biotech, Inc.
10% Owner
Period of report
Sep 30, 2016
Accepted (ET)
Jun 7, 2017 · 5:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001680048
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | Sep 30, 2016 | A | 47,870 | $0.00 | A | 9,047,870 | D | |
| Common Stock, $0.0001 par value | Oct 25, 2016 | A | 27,264 | $0.00 | A | 9,075,134 | D | |
| Common Stock, $0.0001 par value | Nov 30, 2016 | A | 47,505 | $0.00 | A | 9,122,639 | D | |
| Common Stock, $0.0001 par value | Dec 12, 2016 | A | 11,925 | $0.00 | A | 9,134,564 | D | |
| Common Stock, $0.0001 par value | Dec 29, 2016 | A | 15,806 | $0.00 | A | 9,150,370 | D | |
| Common Stock, $0.0001 par value | Jan 31, 2017 | A | 213,419 | $0.00 | A | 9,363,789 | D | |
| Common Stock, $0.0001 par value | Mar 13, 2017 | A | 767,264 | $0.00 | A | 10,131,053 | D | |
| Common Stock, $0.0001 par value | Mar 31, 2017 | A | 1,600 | $0.00 | A | 10,132,653 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class A Preferred Stock, $0.0001 par valueF3 | — | holding | — | — | — | — | — | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1The Issuer is required to grant to the Reporting Person an equity fee in shares of the Issuer's Common Stock equal to 2.5% of the gross amount of any debt or equity financing consummated by the Issuer. These shares were granted by the Issuer to the Reporting Person following the closing of an equity financing.
- F2The Reporting Person is entitled to an annual dividend on its outstanding Class A Preferred Stock equal to 2.5% of the Issuer's fully diluted outstanding capitalization on March 13. These shares were granted by the Issuer to the Reporting Person for the 2017 annual dividend.
- F3Each share of the Issuer's Class A Preferred Stock is convertible at any time at the option of the Reporting Person into one share of the Issuer's Common Stock and has no expiration date.